The 2021 Star Ratings Program results have been released, and fewer MA plans received high Star Ratings. What does this mean for plans as we look toward the 2022 Star Ratings timeline?

The 2021 Star Ratings Program results have been released, and fewer MA plans received high Star Ratings. What does this mean for plans as we look toward the 2022 Star Ratings timeline?
Having a strong communications strategy in place with existing members while preparing for a more digitally based Annual Election Period (AEP) will be critical going into 2021 AEP. This AIS Health article explores what we learned from 2020 OEP and what to expect this fall.
With CMS’ release of the Contract Year 2021 Final Rule, MA plans now have some clarity regarding the many Star Ratings proposals made earlier this year.
It’s that time again… the frantic whirl of both bid submission and material development in anticipation of the upcoming plan year and sales/enrollment activities. Here are some things to consider when developing PY2021 materials.
There’s no doubt about it: COVID-19 will change the way we sell Medicare products. Health plans must pivot strategies to navigate the new norms of COVID-19 and an upcoming Presidential election.
Declaring COVID-19 a national emergency has two major implications for Medicare Advantage plans: Allowing for a Special Enrollment Period (SEP) and the opportunity to offer new benefits.
With MA enrollment soaring, COVID-19 presenting still-developing threats to Medicare, and the Medicare Trust fund approaching insolvency, MedPAC continued emphasizing the need for urgently reforming the MA Quality Bonus Program during its April 2nd public meeting.